Abstract:We review some recent developments regarding the concept of cardiometabolic syndrome and its relation with hypertension and overall cardiovascular disease risk. We emphasize how this new clinical entity has helped to understand multimorbidity in chronic diseases. This concept has important consequences for individual patient treatment as well as public health policy. The challenge derived from cardiovascular disease and other chronic conditions is increasing worldwide, but the highest burden is located in the developing world. Thus, new and cost-effective approaches are needed for diseases that are mainly occurring in the poorest and less educated populations. We illustrate this situation analyzing hypertension and cardiometabolic syndrome data derived from a recent national health survey in Chile.Keywords: hypertension, metabolic syndrome, cardiometabolic syndrome, cardiovascular disease, cardiovascular risk, epidemiology.The purpose of this review is to summarize and discuss some recent developments regarding the concept of cardiometabolic syndrome and its relation with hypertension and overall cardiovascular risk. By describing the findings of the recent first Chilean National Health Survey (MINSAL: 2003), we wish to emphasize the challenges posed by these conditions to developing countries.Hypertension and cardiometabolic syndrome: the case of Chile ENS was conducted and aimed at measuring the simultaneous population burden and distribution of 21 chronic conditions. ENS 2003 was a crosssectional household survey using a stratified multistage probability sample of non-institutionalized adults over 17 years of age. Three thousand six hundred and nineteen subjects were enrolled; the response rate was 63.5% and the refusal rate was 7.5%. A detailed report, including study protocols and manuals, is available on its website [MINSAL, 2003].Prevalence rates were based on internationally accepted cut-offs, weighted for complex sample design and adjusted to represent the Chilean 2003 population. Hypertension screening was measured for public health surveillance purposes.

No abstract

No abstract

En estos días hemos cumplido el día 100 de circulación del SARS CoV-2 en nuestro país, una infección por un nuevo agente, sin tratamiento eficaz y aún sin vacuna disponible.Coronavirus  y  COVID-19  han  sido  los  términos  mas usados  en  la  conversación  diaria  como  también  en  los medios de difusión siendo percibidos como una amenaza y preocupación para la población general, el personal de salud y las autoridades del país. El informe epidemiológico N 17 del 18 de junio del 2020, comunicó que un total de 250.919 casos de COVID 19 han sido diagnosticados, la gran mayoría de ellos han evolucionado en  forma  ambulatorio  y,  solo  7,4%  han  requerido  de hospitalización para asistencia y soporte de complicaciones pulmonares y/o compromiso general de distintos órganos, en centros hospitalario a lo largo de todo el país. La cifra de letalidad global es de alrededor de 1,8%.

No abstract